FDA warns Abbott's FreeStyle Libre 3 blood glucose sensors linked to seven deaths, 736 injuries due to incorrect readings from manufacturing defect.
The U.S. Food and Drug Administration has issued a recall of glucose monitors used by those with diabetes for malfunctioning.
Some FreeStyle Libre 3 glucose sensors made by Abbott Diabetes Care may give incorrect low readings. The devices have been ...
The Food and Drug Administration has issued an alert concerning two glucose monitors with a “high-risk” sensor issue. Abbott Diabetes Care initiated a “medical device correction” on Nov. 24, for ...
Abbott Diabetes Care is warning patients to stop using certain glucose monitors that have been recalled following the deaths of seven people.
MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now ...
FreeStyle Libre is a continuous glucose monitoring (CGM) system. It uses a sensor to read and check a person’s glucose levels. People with diabetes can use FreeStyle Libre to help manage the condition ...